Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

345
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
345
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

320
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
320
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

318
Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
318
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

271
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
271
Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

297
Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
297
Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant01:25

Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant

209
In patients with renal disease, dosage adjustments are necessary to maintain therapeutic plasma drug concentrations and prevent toxicity or subtherapeutic exposure. Renal impairment alters drug pharmacokinetics, especially in conditions like uremia, where changes such as prolonged elimination half-life and altered apparent volume of distribution can significantly affect drug disposition. These changes require careful modification of the dosing regimen to achieve the desired clinical...
209

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Drug-coated balloon treatment of in-stent restenosis in complex severe cardiac allograft vasculopathy.

JHLT open·2026
Same author

Antibody-mediated rejection after heart transplantation: diagnostic gaps, suboptimal outcomes, and emerging tools.

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation·2026
Same author

Elevations in Donor-Derived Cell-Free DNA and Allograft Outcomes in Kidney Transplantation.

Journal of the American Society of Nephrology : JASN·2026
Same author

The Demographic Tide: How Aging and Comorbidity are Reversing Hard-won Gains in Kidney Allograft Survival.

Transplantation·2026
Same author

Fulminant Acanthamoeba Encephalitis Diagnosed By Cell-Free DNA in a Renal Transplant Patient: A Case Report.

Transplantation proceedings·2026
Same author

Qualified prediction system for allograft failure in real world settings: extended validation study.

BMJ medicine·2026

Related Experiment Video

Updated: Jan 18, 2026

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
07:13

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Published on: April 12, 2021

4.9K

Predicting Simultaneous Heart Kidney Allocation and Posttransplant Adverse Kidney Outcomes.

Mutlu Mete1, Mehmet U S Ayvaci2, Ahmet B Gungor3

  • 1Department of Information Science, University of North Texas, Denton, Texas, USA.

Kidney International Reports
|January 16, 2026
PubMed
Summary
This summary is machine-generated.

Predicting kidney recovery after heart transplant is crucial for simultaneous heart-kidney transplantation (SHKT) decisions. A machine learning model shows promise in identifying patients at risk for adverse kidney outcomes post-heart transplantation (HT).

Keywords:
allocationheart transplantmachine learningpredictionrandom forestsimultaneous heart kidney transplantation

More Related Videos

Robot-Assisted Kidney Transplantation
07:30

Robot-Assisted Kidney Transplantation

Published on: July 19, 2021

4.2K
Mouse Kidney Transplantation: Models of Allograft Rejection
16:15

Mouse Kidney Transplantation: Models of Allograft Rejection

Published on: October 11, 2014

21.6K

Related Experiment Videos

Last Updated: Jan 18, 2026

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
07:13

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Published on: April 12, 2021

4.9K
Robot-Assisted Kidney Transplantation
07:30

Robot-Assisted Kidney Transplantation

Published on: July 19, 2021

4.2K
Mouse Kidney Transplantation: Models of Allograft Rejection
16:15

Mouse Kidney Transplantation: Models of Allograft Rejection

Published on: October 11, 2014

21.6K

Area of Science:

  • Cardiology
  • Nephrology
  • Transplantation Medicine
  • Machine Learning in Healthcare

Background:

  • Simultaneous heart-kidney transplantation (SHKT) offers improved survival for patients with end-stage heart failure and kidney disease.
  • Predicting kidney recovery post-heart transplantation (HT) is challenging, complicating SHKT decision-making.
  • Accurate prognostication is essential for optimizing treatment strategies in combined organ failure.

Purpose of the Study:

  • To develop and validate a machine learning model to predict adverse kidney outcomes within one year following heart transplantation (HT).
  • To assist in the clinical decision-making process for simultaneous heart-kidney transplantation (SHKT) in patients with moderate kidney failure.
  • To identify HT recipients who may benefit from or require SHKT based on predicted kidney function.

Main Methods:

  • A retrospective cohort of adult HT recipients in the US (October 2018 - December 2020) was analyzed using Organ Procurement and Transplantation Network (OPTN) data.
  • A random forest (RF) machine learning algorithm was developed using 15 high-importance variables to predict a composite adverse kidney outcome within one year post-HT.
  • Adverse outcomes included need for SHKT, end-stage kidney disease requiring dialysis, severely reduced GFR, or retransplant listing. Model validation was performed internally and externally.

Main Results:

  • Of 6579 HT recipients, 13.4% experienced adverse kidney outcomes or received SHKT within one year.
  • The RF model achieved high specificity (0.941-0.955) and negative predictive value (0.940-0.955).
  • Moderate sensitivity (0.605-0.694) and positive predictive value (0.604-0.680) were observed, with strong class differentiation (c-statistics 0.849-0.899).

Conclusions:

  • The developed RF model demonstrates utility in predicting adverse kidney outcomes after heart transplantation.
  • This predictive tool can supplement clinical judgment in the complex decision-making process for SHKT.
  • Further refinement may enhance its role in patient selection for combined heart and kidney transplantation.